trending Market Intelligence /marketintelligence/en/news-insights/trending/4cdfprfhixc0y-8r9tigva2 content esgSubNav
In This List

Chembio Diagnostics adds director to board

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Chembio Diagnostics adds director to board

Medford, N.Y.-based Chembio Diagnostics Inc., a healthcare supplies company, appointed Mary Polan as director.

Polan is director of Quidel Corp. and Motif BioSciences Inc.

Chembio Diagnostics and its units develop, manufacture and commercialize point-of-care diagnostic tests used to detect or monitor diseases.